Related Experiment Video
Updated: Feb 12, 2026
14:42
Isolation and Analysis of Hematopoietic Stem Cells from the Placenta
Published on: June 24, 2008
21.1K
Placenta accreta complicated with peripartum cardiomyopathy
Yuditiya Purwosunu1, Agrifa Hasiholan Haloho1
1Department of Obstetrics and Gynaecology, University of Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
BMJ Case Reports
|March 26, 2018
Summary
This case study highlights the complex management of a pregnant patient with both placenta accreta and peripartum cardiomyopathy. Successful surgical delivery and intensive care were crucial for patient stabilization.
Area of Science:
- Obstetrics and Gynecology
- Cardiology
- Critical Care Medicine
Background:
- Patient presented with placenta accreta, a high-risk obstetric condition.
- Diagnosis of peripartum cardiomyopathy identified during perioperative assessment.
- Co-existing conditions posed significant management challenges.
Observation:
- A 33-year-old G2P1 patient underwent a caesarean hysterectomy at 36 weeks gestation.
- Significant blood loss (2L) occurred during the procedure.
- Hemodynamic management required a multi-faceted approach including fluid therapy, blood transfusions, and vasoactive/hemostatic medications.
Findings:
- The patient required intensive care unit (ICU) management postoperatively.
- Hemodynamic stability was achieved within 24 hours.
- Successful transfer from ICU to intermediate care, then to the obstetrics ward.
Implications:
- This case underscores the critical need for multidisciplinary collaboration in managing complex obstetric cases.
- Effective perioperative strategies are essential for patients with concurrent cardiac and placental abnormalities.
- Prompt and intensive postoperative care can lead to favorable outcomes in high-risk pregnancies.
Related Concept Videos
01:30Cardiomyopathy II: Dilated Cardiomyopathy
589
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
589
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
526
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
526
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
587
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
587
01:29Cardiomyopathy V: Interprofessional Care
470
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
470
01:25Cardiomyopathy I: Introduction and Classification
619
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
619
01:29Cardiomyopathy VI: Nursing Management
365
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
365